There is no known cure for GBM so research in this area is a key priority for us.
Our pioneering partnership with QMUL is now in its fifth year and has seen us invest over £1.5 million to date, with an additional funding in excess of £400,000 being granted for 2018/19.
In common with all of our Centres, we conduct a quinquennial (five-year) review of research progress made during our funding period. These reviews are carried out by an international team of expert peer reviewers. For our Queen Mary Centre of Excellence, this will take place in 2019.
We look forward to continuing our support for this vital work whilst encouraging the Centre to achieve further external funding to help them to build on the crucial foundation blocks we have laid.
We will be reporting back on the progress and discoveries being made here, what implications this could have for new and improved treatments for glioblastoma patients, and in bringing us closer to a cure for brain tumours.
To keep up to date with all our latest research news, please subscribe to our e-news bulletins and join our mailing list.
- Brain Tumour Research Centre Leads get together for collaborative talks
- Outcomes of immunotherapy vaccine trial show encouraging results for glioblastoma patients